The Rubicon Research IPO comprised a fresh issue of ₹500 crore and an offer-for-sale (OFS) worth ₹877.5 crore by promoter General Atlantic Singapore RR Pte Ltd. Of the fresh issue proceeds, ₹310 crore...
Browsing Tag: pharma IPOs 2025
Trending
The Rubicon Research IPO comprised a fresh issue of ₹500 crore and an offer-for-sale (OFS) worth ₹877.5 crore by promoter General Atlantic Singapore RR Pte Ltd. Of the fresh issue proceeds, ₹310 crore...